arrow
M

Moses Rodriguez

university of utah
H指数:94
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal stability of dietary intake patterns in pediatric-onset multiple sclerosis: A multicenter prospective cohort study

儿科发病多发性硬化症患者膳食摄入模式的纵向稳定性:一项多中心前瞻性队列研究

2026-09-010
PRE
Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosis

扁桃体腺样体切除术与儿童期发病多发性硬化症的风险增加和疾病活动性相关

2026-05-290
PRE
Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis

从口服或静脉输注改为注射型疾病修正疗法在儿童多发性硬化中的真实世界有效性

2025-11-060
OAAI
Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry

评估使用Avonex或Plegridy治疗儿童多发性硬化患者的疗效结局:基于USNPMSC注册研究

2025-09-010
PRE
Distinct plasma lipids predict axonal injury and multiple sclerosis activity
2024-09-120
PRE
Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study
2024-09-010
OA
Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease
2024-07-042
PRE
Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments
2023-08-019
PRE
Mechanisms of metabolic stress induced cell death of human oligodendrocytes: relevance for progressive multiple sclerosis

代谢应激诱导人少突胶质细胞死亡的机制: 与进行性多发性硬化的相关性

2023-07-057
OAAI
Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas
2023-06-207
OAAI
Real-world effectiveness of switching treatment after initial platform injectable disease-modifying therapies in pediatric multiple sclerosis in the US
2023-04-250
PRE
Longitudinal Cognitive Screening Findings in Pediatric MS vs. Pediatric Controls and Adult MS in a Multi-center Cohort
2023-04-250
PRE
Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity
2023-04-016
OAAI
Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder
2023-02-282
OA